Abbott Laboratories

NYSE:ABT   3:59:59 PM EDT
122.13
+1.21 (+1.00%)
4:00:00 PM EDT: $122.12 -0.01 (-0.01%)
Products

Abbott's Xience Stent Receives FDA Approval For Shortest Blood Thinner Course For High Bleeding Risk Patients

Published: 06/30/2021 13:44 GMT
Abbott Laboratories (ABT) - Abbott's Xience Stent Receives FDA Approval for Shortest Blood Thinner Course for High Bleeding Risk Patients.